Development and validation of a prognostic score for overall survival integrating baseline metabolically active tumor volume measured by 18F-FDG PET/CT and clinical factors for metastatic colorectal cancer patients.

Erwin Woff,Alain Hendlisz,Lisa Salvatore,Federica Marmorino,Alfredo Falcone,Dario Genovesi,Assuero Giorgetti,Gabriela Critchi,Lieveke Ameye,Marianne Paesmans,Thomas Guiot,Hugo Levillain,Patrick Flamen

Development and validation of a prognostic score for overall survival integrating baseline metabolically active tumor volume measured by 18F-FDG PET/CT and clinical factors for metastatic colorectal cancer patients.

2019

Erwin Woff
Alain Hendlisz
Lisa Salvatore
Federica Marmorino
Alfredo Falcone
Dario Genovesi
Assuero Giorgetti
Gabriela Critchi
Lieveke Ameye
Marianne Paesmans
Thomas Guiot
Hugo Levillain
Patrick Flamen

3543Background: This study aimed to develop and validate a prognostic score integrating baseline metabolically active tumor volume (MATV) and clinical factors in metastatic colorectal cancer (mCRC)...

Keywords:

Oncology
Prognostic score
Colorectal cancer
PET-CT
Pathology
Internal medicine
Medicine
fdg pet ct
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations